ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years
Chenjie Zhou
Matched on ORCID iD 0000-0002-8774-6846; OpenAlex author ID A5101796539. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2021: 2 papers · 2022: none · 2023: none · 2024: 3 papers
Papers 5
- YBX1 as a therapeutic target to suppress the LRP1-β-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2024.217197↗
- Transcription factor EB reprograms branched-chain amino acid metabolism and promotes pancreatic cancer progression via transcriptional regulation of BCAT1. Co-author DOI 10.1111/cpr.13694↗
- Computed tomography and guidelines-based human-machine fusion model for predicting resectability of the pancreatic cancer. Co-author DOI 10.1111/jgh.16401↗
- UGT1A Gene Family Members Serve as Potential Targets and Prognostic Biomarkers for Pancreatic Cancer. Co-author DOI 10.1155/2021/6673125↗
- Comprehensive Analysis of E3 Ubiquitin Ligases Reveals Ring Finger Protein 223 as a Novel Oncogene Activated by KLF4 in Pancreatic Cancer. Last author DOI 10.3389/fcell.2021.738709↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Lei Feng · 3 shared papers, 2021–2024 · strength 0.47
- Paper Computed tomography and guidelines-based human-machine fusion model for predicting resectability of the pancreatic canc… DOI 10.1111/jgh.16401↗
- Paper Comprehensive Analysis of E3 Ubiquitin Ligases Reveals Ring Finger Protein 223 as a Novel Oncogene Activated by KLF4 in… DOI 10.3389/fcell.2021.738709↗
- Paper UGT1A Gene Family Members Serve as Potential Targets and Prognostic Biomarkers for Pancreatic Cancer. DOI 10.1155/2021/6673125↗
- Xiaowu Xu · 2 shared papers, 2024 · strength 0.38
- Paper YBX1 as a therapeutic target to suppress the LRP1-β-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic… DOI 10.1016/j.canlet.2024.217197↗
- Paper Transcription factor EB reprograms branched-chain amino acid metabolism and promotes pancreatic cancer progression via … DOI 10.1111/cpr.13694↗
- Borui Li · 2 shared papers, 2024 · strength 0.38
- Paper YBX1 as a therapeutic target to suppress the LRP1-β-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic… DOI 10.1016/j.canlet.2024.217197↗
- Paper Transcription factor EB reprograms branched-chain amino acid metabolism and promotes pancreatic cancer progression via … DOI 10.1111/cpr.13694↗
- Qifeng Zhuo · 2 shared papers, 2024 · strength 0.38
- Paper YBX1 as a therapeutic target to suppress the LRP1-β-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic… DOI 10.1016/j.canlet.2024.217197↗
- Paper Transcription factor EB reprograms branched-chain amino acid metabolism and promotes pancreatic cancer progression via … DOI 10.1111/cpr.13694↗
- Xianjun Yu · 2 shared papers, 2024 · strength 0.38
- Paper YBX1 as a therapeutic target to suppress the LRP1-β-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic… DOI 10.1016/j.canlet.2024.217197↗
- Paper Transcription factor EB reprograms branched-chain amino acid metabolism and promotes pancreatic cancer progression via … DOI 10.1111/cpr.13694↗
- Shunrong Ji · 2 shared papers, 2024 · strength 0.38
- Paper YBX1 as a therapeutic target to suppress the LRP1-β-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic… DOI 10.1016/j.canlet.2024.217197↗
- Paper Transcription factor EB reprograms branched-chain amino acid metabolism and promotes pancreatic cancer progression via … DOI 10.1111/cpr.13694↗
- Yi Gao · 2 shared papers, 2021–2024 · strength 0.35
- Paper Computed tomography and guidelines-based human-machine fusion model for predicting resectability of the pancreatic canc… DOI 10.1111/jgh.16401↗
- Paper Comprehensive Analysis of E3 Ubiquitin Ligases Reveals Ring Finger Protein 223 as a Novel Oncogene Activated by KLF4 in… DOI 10.3389/fcell.2021.738709↗
- Shulong Li · 1 shared paper, 2024 · strength 0.22
- Adilijiang Yimamu · 1 shared paper, 2024 · strength 0.22
- Faliang Xing · 1 shared paper, 2024 · strength 0.20
- Zheng Li · 1 shared paper, 2024 · strength 0.20
- Zheng Li · 1 shared paper, 2024 · strength 0.18
- Ting Wang · 1 shared paper, 2024 · strength 0.18
- Yi Qin · 1 shared paper, 2024 · strength 0.18
- Yi Gao · 1 shared paper, 2021 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.